Amylyx Pharmaceuticals, Inc.(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AMLX Amylyx Pharmaceuticals, Inc.

未开盘 11-04 16:00:00 EST

5.70

+0.06

+1.06%

盘后5.70

+0.000.00%

19:59 EST

最高5.80	最低5.50	成交量84.11万
今开5.58	昨收5.64	日振幅5.23%
总市值3.88亿	流通市值2.39亿	总股本6,808万
成交额478.57万	换手率2.00%	流通股本4,200万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AMLX","market":"US","secType":"STK","nameCN":"Amylyx Pharmaceuticals, Inc.","latestPrice":5.7,"timestamp":1730754000000,"preClose":5.64,"halted":0,"volume":841141,"hourTrading":{"tag":"盘后","latestPrice":5.7,"preClose":5.7,"latestTime":"19:59 EST","volume":8703,"amount":49609.4445,"timestamp":1730768393106},"delay":0,"floatShares":42000013,"shares":68082468,"eps":-2.459634,"marketStatus":"未开盘","marketStatusCode":0,"change":0.06,"latestTime":"11-04 16:00:00 EST","open":5.58,"high":5.795,"low":5.5,"amount":4785689.6358033,"amplitude":0.052305,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.459634,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1730797200000},"adr":0,"listingDate":1641531600000,"adjPreClose":5.64,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":5.6,"preClose":5.64,"latestTime":"09:12 EST","volume":1918,"amount":10728.212166,"timestamp":1730729562710},"postHourTrading":{"tag":"盘后","latestPrice":5.7,"preClose":5.7,"latestTime":"19:59 EST","volume":8703,"amount":49609.4445,"timestamp":1730768393106},"volumeRatio":0.58717,"impliedVol":0.6048,"impliedVolPercentile":0.0956},"requestUrl":"/m/hq/s/AMLX","defaultTab":"news","newsList":[{"id":"2480887926","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480887926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480887926?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:25","pubTimestamp":1730471139,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时25分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.00%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101222539971a3e18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101222539971a3e18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2478648441","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.06%报5.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478648441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478648441?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:22","pubTimestamp":1730125328,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时22分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.06%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822220898e3ed93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822220898e3ed93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2478959164","title":"Amylyx Pharmaceuticals, Inc.盘中异动 快速拉升5.00%报5.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478959164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478959164?lang=zh_cn&edition=full","pubTime":"2024-10-26 00:49","pubTimestamp":1729874969,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日00时49分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.00%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Iterum Therapeutics Plc、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Immunitybio, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃，换手率分别为834.34%、759.26%、287.94%，振幅较大的相关个股有Iterum Therapeutics Plc、Qualigen Therapeutics, Inc.、Elevai Labs, Inc.，振幅分别为102.56%、91.58%、89.80%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026004929ab7467ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026004929ab7467ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2477489538","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨9.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477489538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477489538?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:31","pubTimestamp":1729690277,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时31分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价急速上涨9.30%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321311895bd4294&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321311895bd4294&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2477863731","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.23%报5.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477863731","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477863731?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:34","pubTimestamp":1729517684,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时34分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.23%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Biovie Inc.、Werewolf Therapeutics, Inc.、Genprex, Inc.涨幅较大，Genprex, Inc.、Biovie Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为635.20%、372.16%、219.40%，振幅较大的相关个股有Biovie Inc.、Celularity Inc C/Wts 16/07/2026 、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为44.26%、39.86%、35.04%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213445971a15cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213445971a15cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2476102444","title":"BUZZ-遗传性疾病药物试验数据良好，Amylyx 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2476102444","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476102444?lang=zh_cn&edition=full","pubTime":"2024-10-18 00:48","pubTimestamp":1729183682,"startTime":"0","endTime":"0","summary":"** 然而，由于在一项晚期试验中未能延缓疾病的进展，该公司于 3 月份从这两个市场撤出了该药物  ** 包括当期亏损在内，该公司股价年累计下跌了 71%，主要原因是该公司撤出了 Relyvrio。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2475075686","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475075686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475075686?lang=zh_cn&edition=full","pubTime":"2024-10-15 21:48","pubTimestamp":1729000090,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日21时48分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.03%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015214811ab6a45d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015214811ab6a45d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2474470275","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474470275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474470275?lang=zh_cn&edition=full","pubTime":"2024-10-09 00:03","pubTimestamp":1728403398,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日00时03分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.03%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Bio-Path Holdings, Inc.、Portage Biotech Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Aditxt, Inc.、Bio-Path Holdings, Inc.、Gri Bio, Inc.较为活跃，换手率分别为2440.48%、2313.14%、250.19%，振幅较大的相关个股有Virios Therapeutics, Inc.、Trevena, Inc.、Bio-Path Holdings, Inc.，振幅分别为46.27%、42.80%、39.93%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009000319a1df1383&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009000319a1df1383&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2473961012","title":"Amylyx Pharmaceuticals, Inc.盘中异动 临近午盘快速上涨5.07%报3.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473961012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473961012?lang=zh_cn&edition=full","pubTime":"2024-10-04 23:52","pubTimestamp":1728057126,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日23时52分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.07%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004235206ab67c03a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004235206ab67c03a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2468621680","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.03%报3.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468621680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468621680?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:01","pubTimestamp":1726840871,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日22时01分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.03%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.50%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920220111a1db7532&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920220111a1db7532&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2460873658","title":"Amylyx Pharmaceuticals, Inc.2024财年第二财季实现净利润-72.70百万美元，同比减少429.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460873658","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460873658?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910643,"startTime":"0","endTime":"0","summary":"8月18日，Amylyx Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-72.70百万美元，同比减少429.41%；其中营业收入为-1.02百万美元，同比减少101.04%，每股基本收益为-1.07美元。从资产负债表来看，Amylyx Pharmaceuticals, Inc.总负债70.85百万美元，其中短期债务2.37百万美元，资产负债比为0.05，流动比率为0.05。机构评级：截至2024年8月18日，当前有6家机构对Amylyx Pharmaceuticals, Inc.目标价做出预测，其中目标均价为4.25美元，其中最低目标价为3.00美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006269f340746&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006269f340746&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX"],"gpt_icon":0},{"id":"2459483480","title":"Amylyx Pharmaceuticals, Inc.盘中异动 下午盘快速拉升5.28%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459483480","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459483480?lang=zh_cn&edition=full","pubTime":"2024-08-15 01:47","pubTimestamp":1723657649,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日01时47分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.28%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Newamsterdam Pharma Co Nv C/Wts 、Unicycive Therapeutics, Inc.、Notable Labs, Ltd.涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm  Plc较为活跃，换手率分别为93.46%、80.79%、70.23%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm  Plc，振幅分别为60.83%、58.52%、49.86%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081501473097198bf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081501473097198bf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2458142525","title":"Amylyx Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.00%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458142525","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458142525?lang=zh_cn&edition=full","pubTime":"2024-08-10 01:34","pubTimestamp":1723224844,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日01时34分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.00%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.30%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810013405aefe2a4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810013405aefe2a4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2457316714","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.32%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457316714","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457316714?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:34","pubTimestamp":1723124086,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时34分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.32%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Anew Medical, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Aditxt, Inc.较为活跃，换手率分别为192.55%、190.75%、46.18%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Generation Bio Co.，振幅分别为41.09%、18.35%、14.41%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808213446aefdf03c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808213446aefdf03c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2457748728","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457748728","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457748728?lang=zh_cn&edition=full","pubTime":"2024-08-08 03:56","pubTimestamp":1723060611,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日03时56分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.08%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.59%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808035652941ff1d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808035652941ff1d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2457028342","title":"Amylyx Pharmaceuticals Inc    预计每股亏损 73 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457028342","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457028342?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:37","pubTimestamp":1722951447,"startTime":"0","endTime":"0","summary":"   * Amylyx Pharmaceuticals Inc    将于8月8日公布截至2024年6月30日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于马萨诸塞州剑桥市的公司的营收预计将从去年同期的9822万美元下降89.1%，至1066.3万美元。* LSEG的分析师平均预计Amylyx Pharmaceuticals Inc每股亏损73美分。* 华尔街对 Amylyx Pharmaceuticals Inc 的 12 个月目标价中位数为 3.75 美元，高于上一次收盘价 1.97 美元。8月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Amylyx Pharmaceuticals Inc    预计每股亏损 73 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0},{"id":"2456719238","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456719238","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456719238?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:38","pubTimestamp":1722609506,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日22时38分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.07%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.08%。其相关个股中，Os Therapies Incorporated、Exicure, Inc.、Dermata Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Exicure, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为4326.93%、636.74%、70.67%，振幅较大的相关个股有Os Therapies Incorporated、Exicure, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为79.69%、64.24%、60.61%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802223826941fd996&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802223826941fd996&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2455513459","title":"Amylyx Pharmaceuticals, Inc.盘中异动 急速上涨5.23%报2.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455513459","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455513459?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:42","pubTimestamp":1722433334,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日21时42分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.23%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731214215aefc7a44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731214215aefc7a44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2452451302","title":"Amylyx Pharmaceuticals, Inc.盘中异动 临近收盘快速下挫5.19%报2.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452451302","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452451302?lang=zh_cn&edition=full","pubTime":"2024-07-19 03:59","pubTimestamp":1721332764,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日03时59分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.19%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.92%。其相关个股中，Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃，换手率分别为3547.26%、2834.57%、1349.05%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.44%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719035925941f8693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719035925941f8693&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2452169171","title":"Amylyx Pharmaceuticals, Inc.盘中异动 临近午盘快速下跌5.08%报2.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452169171","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452169171?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:42","pubTimestamp":1721230959,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时42分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.08%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.06%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717234239aefa289d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717234239aefa289d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amylyx.com","stockEarnings":[{"period":"1week","weight":0.0694},{"period":"1month","weight":0.8269},{"period":"3month","weight":1.8934},{"period":"6month","weight":1.9534},{"period":"1year","weight":-0.6907},{"period":"ytd","weight":-0.6128}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amylyx Pharmaceuticals, Inc.于2014年1月10日根据特拉华州法律成立。他们的任务是开发治疗方法，通过让神经元存活来改变肌萎缩侧索硬化症和一系列神经退行性疾病的治疗模式。该公司正在寻求其候选产品AMX0035的商业化，他们认为这是第一个在ALS患者的大规模临床试验中显示出功能和生存益处的候选药物。该公司相信AMX0035有潜力成为一种基础疗法，这意味着它可以单独使用或与其他疗法结合使用，以改变广泛的神经退行性疾病的治疗模式。","exchange":"NASDAQ","name":"Amylyx Pharmaceuticals, Inc.","nameEN":"Amylyx Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amylyx Pharmaceuticals, Inc.(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Amylyx Pharmaceuticals, Inc.(AMLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Amylyx Pharmaceuticals, Inc.,AMLX,Amylyx Pharmaceuticals, Inc.股票,Amylyx Pharmaceuticals, Inc.股票老虎,Amylyx Pharmaceuticals, Inc.股票老虎国际,Amylyx Pharmaceuticals, Inc.行情,Amylyx Pharmaceuticals, Inc.股票行情,Amylyx Pharmaceuticals, Inc.股价,Amylyx Pharmaceuticals, Inc.股市,Amylyx Pharmaceuticals, Inc.股票价格,Amylyx Pharmaceuticals, Inc.股票交易,Amylyx Pharmaceuticals, Inc.股票购买,Amylyx Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amylyx Pharmaceuticals, Inc.(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Amylyx Pharmaceuticals, Inc.(AMLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}